Diseases, Conditions, Syndromes

Nirsevimab protects infants against RSV-linked hospitalization

Nirsevimab is efficacious for preventing hospitalization for respiratory syncytial virus (RSV)-associated lower respiratory tract infection among infants, according to a study published in the Dec. 28 issue of the New England ...

Diseases, Conditions, Syndromes

Q&A: Expert explains RSV prevention for vulnerable populations

Respiratory syncytial virus (RSV) is a common virus that seriously affects vulnerable populations such as infants, young children and older adults. Dr. Wasem Alsabbagh, associate professor at the University of Waterloo School ...

page 2 from 33